ZA200108238B - Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines. - Google Patents

Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines.

Info

Publication number
ZA200108238B
ZA200108238B ZA200108238A ZA200108238A ZA200108238B ZA 200108238 B ZA200108238 B ZA 200108238B ZA 200108238 A ZA200108238 A ZA 200108238A ZA 200108238 A ZA200108238 A ZA 200108238A ZA 200108238 B ZA200108238 B ZA 200108238B
Authority
ZA
South Africa
Prior art keywords
endoparasiticidal
piperazines
depsipeptides
cyclic depsipeptides
containing cyclic
Prior art date
Application number
ZA200108238A
Other languages
English (en)
Inventor
Achim Harder
Georg Samson-Himmelstjerna
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7907825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200108238(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA200108238B publication Critical patent/ZA200108238B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA200108238A 1999-05-12 2001-10-08 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines. ZA200108238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19921887A DE19921887A1 (de) 1999-05-12 1999-05-12 Endoparasitizide Mittel

Publications (1)

Publication Number Publication Date
ZA200108238B true ZA200108238B (en) 2002-12-24

Family

ID=7907825

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108238A ZA200108238B (en) 1999-05-12 2001-10-08 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines.

Country Status (26)

Country Link
EP (1) EP1189615B1 (hu)
JP (1) JP2002544224A (hu)
KR (1) KR100704717B1 (hu)
CN (1) CN1224391C (hu)
AT (1) ATE258795T1 (hu)
AU (1) AU768910B2 (hu)
BR (1) BR0010499A (hu)
CA (1) CA2373827C (hu)
CZ (1) CZ300782B6 (hu)
DE (2) DE19921887A1 (hu)
DK (1) DK1189615T3 (hu)
ES (1) ES2211558T3 (hu)
HK (1) HK1047228B (hu)
HR (1) HRP20010918B1 (hu)
HU (1) HUP0201201A3 (hu)
MX (1) MXPA01011455A (hu)
NO (1) NO328870B1 (hu)
PL (1) PL200951B1 (hu)
PT (1) PT1189615E (hu)
RS (1) RS50169B (hu)
RU (1) RU2250779C2 (hu)
SK (1) SK285494B6 (hu)
TR (2) TR200103240T2 (hu)
UA (1) UA72520C2 (hu)
WO (1) WO2000069425A2 (hu)
ZA (1) ZA200108238B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
CA3009867C (en) * 2015-12-28 2022-05-31 Merial, Inc. Anthelmintic cyclic depsipeptide compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
WO2022051862A1 (en) * 2020-09-11 2022-03-17 The Governing Council Of The University Of Toronto Piperazinyl compounds and methods for treating nematode infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
JPS6471865A (en) * 1987-09-11 1989-03-16 Nichibai Boeki Kk 1-alkylcarbamoyl-4-methylpiperazine derivative
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
WO1995007272A1 (en) * 1993-09-06 1995-03-16 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
MX9801792A (es) * 1995-09-07 1998-07-31 Upjohn Co Inhibidores cicloantihelminticos.
WO1998037088A1 (en) * 1997-02-19 1998-08-27 Meiji Seika Kaisha Ltd. Derivatives of cyclodepsipeptide, pf1022 substance
CA2292698A1 (en) * 1997-06-04 1998-12-10 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
WO2000008047A1 (fr) * 1998-08-04 2000-02-17 Nisshin Flour Milling Co., Ltd. Derives de depsipeptides comportant des noyaux de piperazinone

Also Published As

Publication number Publication date
CZ300782B6 (cs) 2009-08-12
SK16262001A3 (sk) 2002-03-05
DE19921887A1 (de) 2000-11-16
TR200401875T2 (tr) 2005-01-24
EP1189615B1 (de) 2004-02-04
PL200951B1 (pl) 2009-02-27
RS50169B (sr) 2009-05-06
NO20015398D0 (no) 2001-11-05
NO328870B1 (no) 2010-06-07
HUP0201201A3 (en) 2003-03-28
CA2373827C (en) 2008-09-16
HUP0201201A2 (en) 2002-08-28
KR20010109527A (ko) 2001-12-10
ES2211558T3 (es) 2004-07-16
EP1189615A2 (de) 2002-03-27
DE50005213D1 (de) 2004-03-11
JP2002544224A (ja) 2002-12-24
HRP20010918A2 (en) 2003-04-30
PL351376A1 (en) 2003-04-07
YU80501A (sh) 2004-09-03
TR200103240T2 (tr) 2002-04-22
WO2000069425A3 (de) 2001-03-15
UA72520C2 (uk) 2005-03-15
HK1047228A1 (en) 2003-02-14
NO20015398L (no) 2001-11-05
ATE258795T1 (de) 2004-02-15
HK1047228B (zh) 2006-07-21
AU768910B2 (en) 2004-01-08
CN1224391C (zh) 2005-10-26
SK285494B6 (sk) 2007-02-01
KR100704717B1 (ko) 2007-04-09
BR0010499A (pt) 2002-02-13
CN1352559A (zh) 2002-06-05
RU2250779C2 (ru) 2005-04-27
HRP20010918B1 (en) 2011-01-31
WO2000069425A2 (de) 2000-11-23
CZ20014060A3 (cs) 2002-06-12
DK1189615T3 (da) 2004-06-07
AU5523700A (en) 2000-12-05
PT1189615E (pt) 2004-05-31
CA2373827A1 (en) 2000-11-23
MXPA01011455A (es) 2002-07-30

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
HK1036970A1 (en) Compounds and compositions for delivering active agents.
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
PL347671A1 (en) Compounds and compositions for delivering active agents
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
HK1054918A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR0014381A (pt) Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência
YU13301A (sh) Muskarinski agonisti i antagonisti
FR2765483B1 (fr) Medicament destine a traiter les dysfonctions erectiles
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ZA200108238B (en) Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines.
MY140724A (en) Novel arylethene-sulfonamides
MXPA02012015A (es) Ligandos de receptores para integrinas.
TR200103126T2 (tr) Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri
UA37545A (uk) Калієва сіль n-(1,4-діоксо-3-метил-1,4-дигідронафт-2-іл) гліцину, що проявляє антигіпоксичну та протиішемічну дію